US Stock MarketDetailed Quotes

Alaunos Therapeutics (TCRT)

Watchlist
  • 2.810
  • +0.070+2.55%
Close Jan 15 16:00 ET
6.27MMarket Cap-1.22P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Alaunos Therapeutics (TCRT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-8.07%-844K
58.30%-701K
59.73%-772K
83.51%-4.97M
91.98%-592K
87.75%-781K
75.99%-1.68M
79.57%-1.92M
-3.11%-30.14M
-3.58%-7.39M
Net income from continuing operations
-2.84%-1.16M
6.83%-1.05M
36.21%-1.07M
86.68%-4.68M
90.54%-742K
86.70%-1.13M
87.14%-1.13M
83.26%-1.68M
6.86%-35.14M
14.37%-7.84M
Operating gains losses
--0
----
----
----
----
----
----
----
0.00%7K
---5K
Depreciation and amortization
--0
--0
--0
-99.91%2K
-100.41%-1K
--0
-99.86%1K
-99.71%2K
-16.09%2.32M
-65.27%241K
Other non cash items
----
----
----
----
----
----
----
----
-0.52%1.33M
25.39%-1.1M
Change In working capital
-94.74%14K
120.58%135K
156.97%233K
88.34%-729K
102.57%70K
137.95%266K
49.85%-656K
73.16%-409K
-818.85%-6.25M
-241.42%-2.72M
-Change in receivables
-50.00%2K
--0
--3K
-233.33%-4K
-400.00%-5K
0.00%4K
25.00%-3K
--0
-99.73%3K
-100.03%-1K
-Change in prepaid assets
-51.74%166K
138.13%122K
-145.60%-140K
139.72%539K
116.34%208K
173.66%344K
-195.81%-320K
526.53%307K
-256.52%-1.36M
-2,646.00%-1.27M
-Change in payables and accrued expense
-87.80%-154K
103.90%13K
151.68%370K
73.46%-1.26M
94.49%-133K
76.23%-82K
40.64%-333K
50.42%-716K
-587.16%-4.76M
14.89%-2.41M
-Change in other current liabilities
----
----
----
--0
--0
--0
--0
--0
74.54%-138K
-46.42%965K
Cash from discontinued investing activities
Operating cash flow
-8.07%-844K
58.30%-701K
59.73%-772K
83.51%-4.97M
91.98%-592K
87.75%-781K
75.99%-1.68M
79.57%-1.92M
-3.11%-30.14M
-3.58%-7.39M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
797.41%1.35M
1,716.13%1.5M
Net PPE purchase and sale
----
----
----
--0
--0
--0
--0
--0
797.41%1.35M
1,716.13%1.5M
Cash from discontinued investing activities
Investing cash flow
----
----
----
--0
--0
--0
--0
--0
797.41%1.35M
1,716.13%1.5M
Financing cash flow
Cash flow from continuing financing activities
0
0
0
0
0
0
-384.88%-18.14M
0
Net issuance payments of debt
----
----
----
--0
--0
--0
--0
--0
-117.27%-18.11M
--0
Net common stock issuance
--0
----
----
--0
--0
--0
--0
--0
-99.37%92K
--0
Net preferred stock issuance
--0
----
----
----
----
--0
----
----
----
----
Net other financing activities
----
----
----
----
----
----
----
----
---125K
--0
Cash from discontinued financing activities
Financing cash flow
--0
----
----
--0
--0
--0
--0
--0
-384.88%-18.14M
--0
Net cash flow
Beginning cash position
16.84%2.88M
-92.30%319K
-82.00%1.09M
-88.56%6.06M
-85.91%1.68M
-86.55%2.46M
-88.93%4.15M
-88.56%6.06M
-30.32%53M
-76.92%11.94M
Current changes in cash
-20.49%-941K
252.29%2.56M
59.73%-772K
89.41%-4.97M
89.94%-592K
87.75%-781K
91.21%-1.68M
87.68%-1.92M
-103.55%-46.93M
-570.18%-5.88M
End cash Position
15.15%1.94M
16.84%2.88M
-92.30%319K
-82.00%1.09M
-82.00%1.09M
-85.91%1.68M
-86.55%2.46M
-88.93%4.15M
-88.56%6.06M
-88.56%6.06M
Free cash flow
-20.49%-941K
58.30%-701K
59.73%-772K
83.62%-4.97M
91.98%-592K
87.75%-781K
76.45%-1.68M
79.70%-1.92M
-3.03%-30.34M
-1.92%-7.39M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -8.07%-844K58.30%-701K59.73%-772K83.51%-4.97M91.98%-592K87.75%-781K75.99%-1.68M79.57%-1.92M-3.11%-30.14M-3.58%-7.39M
Net income from continuing operations -2.84%-1.16M6.83%-1.05M36.21%-1.07M86.68%-4.68M90.54%-742K86.70%-1.13M87.14%-1.13M83.26%-1.68M6.86%-35.14M14.37%-7.84M
Operating gains losses --0----------------------------0.00%7K---5K
Depreciation and amortization --0--0--0-99.91%2K-100.41%-1K--0-99.86%1K-99.71%2K-16.09%2.32M-65.27%241K
Other non cash items ---------------------------------0.52%1.33M25.39%-1.1M
Change In working capital -94.74%14K120.58%135K156.97%233K88.34%-729K102.57%70K137.95%266K49.85%-656K73.16%-409K-818.85%-6.25M-241.42%-2.72M
-Change in receivables -50.00%2K--0--3K-233.33%-4K-400.00%-5K0.00%4K25.00%-3K--0-99.73%3K-100.03%-1K
-Change in prepaid assets -51.74%166K138.13%122K-145.60%-140K139.72%539K116.34%208K173.66%344K-195.81%-320K526.53%307K-256.52%-1.36M-2,646.00%-1.27M
-Change in payables and accrued expense -87.80%-154K103.90%13K151.68%370K73.46%-1.26M94.49%-133K76.23%-82K40.64%-333K50.42%-716K-587.16%-4.76M14.89%-2.41M
-Change in other current liabilities --------------0--0--0--0--074.54%-138K-46.42%965K
Cash from discontinued investing activities
Operating cash flow -8.07%-844K58.30%-701K59.73%-772K83.51%-4.97M91.98%-592K87.75%-781K75.99%-1.68M79.57%-1.92M-3.11%-30.14M-3.58%-7.39M
Investing cash flow
Cash flow from continuing investing activities 00000797.41%1.35M1,716.13%1.5M
Net PPE purchase and sale --------------0--0--0--0--0797.41%1.35M1,716.13%1.5M
Cash from discontinued investing activities
Investing cash flow --------------0--0--0--0--0797.41%1.35M1,716.13%1.5M
Financing cash flow
Cash flow from continuing financing activities 000000-384.88%-18.14M0
Net issuance payments of debt --------------0--0--0--0--0-117.27%-18.11M--0
Net common stock issuance --0----------0--0--0--0--0-99.37%92K--0
Net preferred stock issuance --0------------------0----------------
Net other financing activities -----------------------------------125K--0
Cash from discontinued financing activities
Financing cash flow --0----------0--0--0--0--0-384.88%-18.14M--0
Net cash flow
Beginning cash position 16.84%2.88M-92.30%319K-82.00%1.09M-88.56%6.06M-85.91%1.68M-86.55%2.46M-88.93%4.15M-88.56%6.06M-30.32%53M-76.92%11.94M
Current changes in cash -20.49%-941K252.29%2.56M59.73%-772K89.41%-4.97M89.94%-592K87.75%-781K91.21%-1.68M87.68%-1.92M-103.55%-46.93M-570.18%-5.88M
End cash Position 15.15%1.94M16.84%2.88M-92.30%319K-82.00%1.09M-82.00%1.09M-85.91%1.68M-86.55%2.46M-88.93%4.15M-88.56%6.06M-88.56%6.06M
Free cash flow -20.49%-941K58.30%-701K59.73%-772K83.62%-4.97M91.98%-592K87.75%-781K76.45%-1.68M79.70%-1.92M-3.03%-30.34M-1.92%-7.39M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -